Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Improving Survival in Acute Myeloid Leukemia for Adults Aged 18-60 Using Idarubicin, Daunorubicin, Cytarabine, and Mycophenolic Acid

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of Hydrocortisone and Vasopressin (Argipressin) Treatment in Adult Patients with Post-Cardiac Arrest Syndrome and Hemodynamic Failure

    Not recruiting

    3 1 1
    Investigated Diseases:
    France
  • Study comparing enfortumab vedotin versus chemotherapy combination (docetaxel, paclitaxel, vinflunine) in patients with previously treated advanced or metastatic bladder cancer

    Not recruiting

    3 1 1 1
    Portugal Spain
  • Study of Hyperbaric Oxygen Therapy Administered Once or Twice Daily for Patients with Acute Acoustic Trauma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study of Alpelisib, Trastuzumab, and Fulvestrant for Patients with PIK3CA Mutated HER2+ Advanced Breast Cancer Previously Treated with Trastuzumab

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Spain
  • Study on Cetuximab and Irinotecan for Patients with Metastatic Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study on the Effectiveness and Safety of Apalutamide and Stereotactic Radiotherapy for Patients with High-Risk Localized or Locally Advanced Prostate Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Slovakia
  • Study on the Effectiveness and Safety of Endoxifen for Adults with Bipolar I Disorder Experiencing Acute Mania or Manic Episodes

    Not recruiting

    3 1
    Investigated Diseases:
    Romania
  • Study on the Effects of Acetazolamide in Patients with Normal Pressure Hydrocephalus

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden
  • Study of Pembrolizumab and Lenvatinib for Patients with Advanced Liver Cancer Resistant to Previous Immunotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany